Patents by Inventor Kelley A. Smith
Kelley A. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250017857Abstract: Poly(oxazoline) conjugates with pendant cationic groups (cationic POZ) and lipid nanoparticles (LNPs) including cationic POZ used to facilitate delivery of an encapsulated payload. LNPs and polyplexes including cationic POZ and a nucleic acid payload such as, but not limited to, mRNA or modified mRNA are disclosed. Such LNPs have no immunogenicity or reduced immunogenicity as compared to a corresponding LNP containing an ionizable lipid.Type: ApplicationFiled: June 14, 2024Publication date: January 16, 2025Applicant: Serina Therapeutics (AL), Inc.Inventors: Randall Moreadith, J Milton Harris, Kunsang Yoon, Zhihao Fang, Rebecca Weimer, Wookhyun Kim, Kelley Smith
-
Publication number: 20240233697Abstract: A digital piano includes a plurality of keys, a foot pedal mechanism positioned below the plurality of keys, a subwoofer positioned below the plurality of keys, and a controller operably connected to the plurality of keys, the foot pedal mechanism, and the subwoofer, the controller configured to cause the digital piano to produce an audible output based on at least a user input on the plurality of keys, at least a portion of the audible output being emitted by the subwoofer.Type: ApplicationFiled: January 5, 2023Publication date: July 11, 2024Inventors: Benjamin Kelley Smith, Gary Albert Girouard
-
Publication number: 20240221709Abstract: A piano pedal system includes a pedal pivotable, over a full range of movement, between a first position and a second position; a sensor configured to output an electrical signal indicative of a position of the pedal; and a biasing member coupled to the pedal, the biasing member configured to apply a biasing force on the pedal in response to displacement of the pedal from the first position. The biasing force is substantially linear over the full range of movement.Type: ApplicationFiled: December 29, 2022Publication date: July 4, 2024Inventor: Benjamin Kelley Smith
-
Patent number: 10752913Abstract: The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.Type: GrantFiled: December 7, 2007Date of Patent: August 25, 2020Assignee: Dow AgroSciences LLCInventors: Justin M. Lira, Terry R. Wright, Sean M. Russell, Donald J. Merlo, Steven R. Webb, Nicole L. Arnold, Andrew E. Robinson, Kelley A. Smith
-
Publication number: 20200245745Abstract: A three-point knee support system for a watercraft is described. Detachable adjustable shoulder straps and detachable adjustable hip belt straps from a backpack adapted to carry the uninflated or deflated watercraft in the situation where the watercraft is inflatable, are attached to three locations on each of the side walls of the watercraft for holding a paddler's or user's knee against that sidewall, in order to enable the paddler to more easily and accurately control the watercraft.Type: ApplicationFiled: February 3, 2020Publication date: August 6, 2020Applicant: Kokopelli Outdoor, Inc.Inventor: Patrick Kelley Smith
-
Publication number: 20140283225Abstract: The present disclosure relates in part to a method for identifying a soybean germline transformant from a population of soybean transformants which are comprised of a combination of soybean non-germline transformants and soybean germline transformants. The soybean non-germline transformants are identified and eliminated early in the transformation process. The soybean germline transformants are detected and selected for culturing into mature soybean plants. The method is readily applicable for screening and obtaining a soybean germline transformant at an early stage in the transformation process.Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: Dow Agrosciences LLCInventors: Jayakumar Pon Samuel, Sivarama Reddy Chennareddy, Andy Bowling, John Whitteck, Tatyana Minnicks, Dayakar Pareddy, Kerrm Y. Yau, Kelley A. Smith
-
Publication number: 20140173780Abstract: A method is disclosed for the Agrobacterium-mediated germline transformation of soybean, comprising infecting split soybean seeds, with a portion of the embryonic axis, with Agrobacterium tumefaciens containing a transgene. The method can further comprise regenerating the explants produced from the transformation of the split soybean seeds comprising a portion of embryonic axis in vitro on selection medium.Type: ApplicationFiled: December 18, 2013Publication date: June 19, 2014Inventors: Dayakar Pareddy, Sivarama R. Chennareddy, Tatyana Minnicks, Olga Karpova, David Griffin, Jayakumar P. Samuel, Kelley A. Smith, Rodrigo Sarria-Millan, Tejinder Kumar Mall
-
Publication number: 20140173774Abstract: A method is disclosed for the Agrobacterium-mediated germline transformation of soybean, comprising infecting split soybean seeds, with a portion of the embryonic axis, with Agrobacterium tumefaciens containing a transgene. The method can further comprise regenerating the explants produced from the transformation of the split soybean seeds comprising a portion of embryonic axis in vitro on selection medium.Type: ApplicationFiled: December 19, 2013Publication date: June 19, 2014Applicant: Dow AgroSciences LLCInventors: Dayakar Pareddy, Sivarama R. Chennareddy, Tatyana Minnicks, Olga Karpova, David Griffin, Jayakumar P. Samuel, Kelley Smith, Rodrigo Sarria-Milan
-
Patent number: 8632978Abstract: Soybean Event pDAB9582.814.19.1 comprises genes encoding Cry1F, Cry1Ac (synpro), and PAT, affording insect resistance and herbicide tolerance to soybean crops containing the event, and enabling methods for crop protection and protection of stored products. The invention provides PCR event detection methods.Type: GrantFiled: July 26, 2012Date of Patent: January 21, 2014Assignee: Dow AgroSciences, LLC.Inventors: Lauren Clark, Kelley A. Smith, Yang Wang, Ning Zhou
-
Publication number: 20130065230Abstract: Soybean Event pDAB9582.814.19.1 comprises genes encoding Cry1F, Cry1Ac (synpro), and PAT, affording insect resistance and herbicide tolerance to soybean crops containing the event, and enabling methods for crop protection and protection of stored products. The invention provides PCR event detection methods.Type: ApplicationFiled: July 26, 2012Publication date: March 14, 2013Applicant: DOW AGROSCIENCES LLCInventors: Lauren CLARK, Kelley A. SMITH, Yang WANG, Ning ZHOU
-
Patent number: 7982006Abstract: This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) ?-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.Type: GrantFiled: June 23, 2010Date of Patent: July 19, 2011Assignee: Dow AgroSciences LLCInventors: William M. Ainley, Janna Armstrong, Krishna Madduri, Donald J. Merlo, Kelley A. Smith, Mark A. Thompson, Steven R. Webb, Liu Y. Shen
-
Publication number: 20110107455Abstract: The subject invention relates to a novel gene referred to herein as DSM-2. This gene was identified in Sterptomyces coelicolor A3. The DSM-2 protein is distantly related to PAT and BAR. The subject invention also provides plant-optimized genes encoding DSM-2 proteins, DSM-2 can be used as a transgenic trait to impart tolerance in plants and plant cells to the herbicides glufosinate and bialaphos. One preferred use of the subject genes are as selectable markers. The use of this gene as a selectable marker in a bacterial system can increase efficiency for plant transformations. Use of DSM-2 as the sole selection marker eliminates the need for an additional medicinal antibiotic marker (such as ampicillin resistance) during cloning. Various other uses are also possible according to the subject invention.Type: ApplicationFiled: December 7, 2007Publication date: May 5, 2011Applicant: Dow AgroSciences LLCInventors: Justin M. Lira, Terry R. Wright, Sean M. Russell, Donald J. Merlo, Steven Robert Webb, Nicole L. Arnold, Andrew E. Robinson, Kelley A. Smith
-
Patent number: 7888069Abstract: The subject application provides various compositions of matter directed to West Nile virus (WNV) polypeptides and fragments thereof and polynucleotides, vectors and transformed host cells that encode, direct the expression of, or produce WNV polypeptides as set forth herein. Methods of using the polypeptides and polynucleotides for the production of immune responses in individuals or detecting the presence of WNV specific or neutralizing antibodies are also provided herein.Type: GrantFiled: December 21, 2007Date of Patent: February 15, 2011Assignees: Dow Agrosciences LLC, The United States of America as represented by the Secretary of ArgricultureInventors: Kelley A. Smith, Steven R. Webb, Steven L. Evans, Charles A. Mihaliak, Donald J. Merlo, Geoffrey J. Letchworth
-
Publication number: 20100261884Abstract: This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) ?-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.Type: ApplicationFiled: June 23, 2010Publication date: October 14, 2010Applicant: Dow AgroSciences LLCInventors: William M. Ainley, Janna Armstrong, Krishna Madduri, Donald J. Merlo, Kelley A. Smith, Mark A. Thompson, Steven R. Webb, Liu Y. Shen
-
Patent number: 7745175Abstract: This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) ?-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.Type: GrantFiled: October 26, 2007Date of Patent: June 29, 2010Assignee: Dow AgroSciences LLCInventors: William M. Ainley, Janna Armstrong, Krishna Madduri, Donald J. Merlo, Kelley A. Smith, Mark A. Thompson, Steven R. Webb, Liu Y. Shen
-
Publication number: 20090069229Abstract: The subject application provides various compositions of matter directed to West Nile virus (WNV) polypeptides and fragments thereof and polynucleotides, vectors and transformed host cells that encode, direct the expression of, or produce WNV polypeptides as set forth herein. Methods of using the polypeptides and polynucleotides for the production of immune responses in individuals or detecting the presence of WNV specific or neutralizing antibodies are also provided herein.Type: ApplicationFiled: December 21, 2007Publication date: March 12, 2009Inventors: Kelley A. Smith, Steven R. Webb, Steven L. Evans, Charles A. Mihaliak, Donald J. Merlo, Geoffrey Letchworth
-
Publication number: 20080102079Abstract: This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) ?-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.Type: ApplicationFiled: October 26, 2007Publication date: May 1, 2008Applicant: Dow AgroSciences LLCInventors: William Ainley, Janna Armstrong, Krishna Madduri, Donald Merlo, Kelley Smith, Mark Thompson, Steven Webb, Liu Shen
-
Patent number: 7179902Abstract: The present invention provides DNA sequences that function as 3? untranslated regions (3?UTR) in plants. The 3?UTR's stabilize associated recombinant transcripts such that expression is improved. The invention further provides plant expression cassettes and recombinant plant that comprise a claimed 3?UTR.Type: GrantFiled: June 25, 2003Date of Patent: February 20, 2007Assignee: Dow AgroSciences LLCInventors: Neil M. Cowen, Katherine Armstrong, Kelley A. Smith
-
Patent number: 7071385Abstract: The promoter from the maize actin depolymerizing factor gene is useful in controlling transgene expression in plants.Type: GrantFiled: March 4, 2003Date of Patent: July 4, 2006Assignee: Dow AgroSciences LLCInventors: Beth C. Rubin-Wilson, Kelley A. Smith
-
Publication number: 20050066392Abstract: The present invention relates to nucleic acid and amino acid sequences that confer herbicide resistance in plants, as well as herbicide resistance in plants, plant seeds, plant tissues and plant cells comprising such sequences. In a preferred embodiment, the sequences of the present invention confer a tolerant phenotype in plants in response to a chronic and/or acute inhibitin dose of auxinic herbicides. The present invention also provides homologous sequences with a high degree of functional similarity.Type: ApplicationFiled: August 30, 2002Publication date: March 24, 2005Inventors: Vipula Shukla, Kelley Smith, Theodore Letherer, James Connell, Ignacio Larrinua, Kelley Ralph